Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response
- PMID: 38336872
- PMCID: PMC11443038
- DOI: 10.1093/rheumatology/keae076
Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response
Abstract
Objectives: Interstitial lung disease (ILD) in CTDs has highly variable morphology. We aimed to identify imaging features and their impact on ILD progression, mortality, and immunosuppression response.
Methods: Patients with CTD-ILD had high-resolution chest CT (HRCT) reviewed by expert radiologists blinded to clinical data for overall imaging pattern [usual interstitial pneumonia (UIP); non-specific interstitial pneumonia (NSIP); organizing pneumonia (OP); fibrotic hypersensitivity pneumonitis (fHP); and other]. Transplant-free survival and change in percent-predicted forced vital capacity (FVC) were compared using Cox and linear mixed-effects models adjusted for age, sex, smoking, and baseline FVC. FVC decline after immunosuppression was compared with pre-treatment.
Results: Among 645 CTD-ILD patients, the most frequent CTDs were SSc (n = 215), RA (n = 127), and inflammatory myopathies (n = 100). NSIP was the most common pattern (54%), followed by UIP (20%), fHP (9%), and OP (5%). Compared with the case for patients with UIP, FVC decline was slower in patients with NSIP (by 1.1%/year, 95% CI 0.2, 1.9) or OP (by 3.5%/year, 95% CI 2.0, 4.9), and mortality was lower in patients with NSIP [hazard ratio (HR) 0.65, 95% CI 0.45, 0.93] or OP (HR 0.18, 95% CI 0.05, 0.57), but higher in fHP (HR 1.58, 95% CI 1.01, 2.40). The extent of fibrosis also predicted FVC decline and mortality. After immunosuppression, FVC decline was slower compared with pre-treatment in NSIP (by 2.1%/year, 95% CI 1.4, 2.8), with no change for UIP or fHP.
Conclusion: Multiple radiologic patterns are possible in CTD-ILD, including a fHP pattern. NSIP and OP were associated with better outcomes and response to immunosuppression, while fHP had worse survival compared with UIP.
Keywords: connective tissue disease; interstitial lung disease; prognosis; radiologic patterns.
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures




Similar articles
-
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26. Kaohsiung J Med Sci. 2019. PMID: 30913371 Free PMC article.
-
Pathological features of connective tissue disease-associated interstitial lung disease in transbronchial cryobiopsies.Histopathology. 2025 Jan;86(2):260-267. doi: 10.1111/his.15311. Epub 2024 Sep 2. Histopathology. 2025. PMID: 39223069
-
Lung-Dominant Connective Tissue Disease: Clinical, Radiologic, and Histologic Features.Chest. 2015 Dec;148(6):1438-1446. doi: 10.1378/chest.14-3174. Chest. 2015. PMID: 25950648
-
Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Chron Respir Dis. 2011;8(1):53-82. doi: 10.1177/1479972310393758. Chron Respir Dis. 2011. PMID: 21339375 Review.
-
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.Eur J Radiol Open. 2022 Apr 7;9:100419. doi: 10.1016/j.ejro.2022.100419. eCollection 2022. Eur J Radiol Open. 2022. PMID: 35445144 Free PMC article. Review.
Cited by
-
Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren's Syndrome.J Clin Med. 2024 Aug 22;13(16):4963. doi: 10.3390/jcm13164963. J Clin Med. 2024. PMID: 39201105 Free PMC article.
-
Potential of phosphodiesterase 4B inhibition in the treatment of progressive pulmonary fibrosis.Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666241309795. doi: 10.1177/17534666241309795. Ther Adv Respir Dis. 2025. PMID: 39745090 Free PMC article. Review.
-
Clinical, radiologic, and serologic predictors of rheumatic disease in interstitial lung disease patients.Clin Rheumatol. 2025 Jul;44(7):2951-2960. doi: 10.1007/s10067-025-07505-w. Epub 2025 Jun 11. Clin Rheumatol. 2025. PMID: 40500569 Free PMC article.
-
Serum inflammatory markers as predictors of therapeutic response in non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease: a retrospective cohort analysis.BMC Pulm Med. 2025 May 10;25(1):229. doi: 10.1186/s12890-025-03703-z. BMC Pulm Med. 2025. PMID: 40348969 Free PMC article.
-
Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registry.Respir Res. 2025 Feb 28;26(1):73. doi: 10.1186/s12931-025-03136-6. Respir Res. 2025. PMID: 40022059 Free PMC article.
References
-
- Marinescu D-C, Hague CJ, Muller NL et al. Integration and application of radiologic patterns from clinical practice guidelines on idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. CHEST 2023;164:1466–75. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous